These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8127625)

  • 21. Get the facts straight.
    Kopans DB
    J Clin Oncol; 2004 Dec; 22(23):4859; author reply 4860-2. PubMed ID: 15570093
    [No Abstract]   [Full Text] [Related]  

  • 22. [40 years breast carcinoma treatment in the Neubrandenburg region.Can an increase in prognostically more favorable stages be detected?].
    Rühle H; Grobe N; Balschat S; Ernst KF; Dewitz D; Winkler L
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):135-7. PubMed ID: 9244654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
    Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
    Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Gothenburg Breast Screening Trial.
    Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
    Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screen-detected breast cancers have a lower mitotic activity index.
    Groenendijk RP; Bult P; Tewarie L; Peer PG; van der Sluis RF; Ruers TJ; Wobbes T
    Br J Cancer; 2000 Jan; 82(2):381-4. PubMed ID: 10646892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-parametric estimation of the post-lead-time survival distribution of screen-detected cancer cases.
    Xu JL; Prorok PC
    Stat Med; 1995 Dec; 14(24):2715-25. PubMed ID: 8619110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of survival differences between clinically and screen-detected cancer patients.
    Habbema JD; van Oortmarssen GJ; van Putten DJ
    Stat Med; 1983; 2(2):279-85. PubMed ID: 6648143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The breast cancer screening controversy continues.
    Ross JM; Gerber P
    Ann Intern Med; 1993 May; 118(9):747; author reply 748-9. PubMed ID: 8379981
    [No Abstract]   [Full Text] [Related]  

  • 29. The meaning of "adjusted" and "observed" survival rates.
    Lawrence GA
    CA Cancer J Clin; 1998; 48(3):189-90. PubMed ID: 9594921
    [No Abstract]   [Full Text] [Related]  

  • 30. Natural history of breast cancer.
    Rubens RD; Gregory WM
    Lancet; 1992 Mar; 339(8796):810-1. PubMed ID: 1347832
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognosis and pathology of screen-detected carcinomas: how different are they?
    Nagtegaal ID; Allgood PC; Duffy SW; Kearins O; Sullivan EO; Tappenden N; Wallis M; Lawrence G
    Cancer; 2011 Apr; 117(7):1360-8. PubMed ID: 21425135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for breast cancer.
    Duffy SW; Smith RA; Gabe R; Tabár L; Yen AM; Chen TH
    Surg Oncol Clin N Am; 2005 Oct; 14(4):671-97. PubMed ID: 16226686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screen-detected breast carcinomas--do they differ from those diagnosed outside screening programs?
    Toikkanen S; Dean PB; Joensuu H
    Pathol Annu; 1994; 29 Pt 1():261-79. PubMed ID: 8127625
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening mammography may not be effective at any age.
    Wilkerson BF; Schooff M
    J Fam Pract; 2000 Apr; 49(4):302, 371. PubMed ID: 10778833
    [No Abstract]   [Full Text] [Related]  

  • 35. The debate on breast cancer screening with mammography is important.
    Gøtzsche PC
    J Am Coll Radiol; 2004 Jan; 1(1):8-14. PubMed ID: 17411511
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Paci E; Ponti A; Crocetti E; Zappa M; Segnan N
    J Natl Cancer Inst; 2005 Dec; 97(24):1853-4; author reply 1854. PubMed ID: 16368949
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.